Your browser doesn't support javascript.
loading
Canadian patient experiences of lupus nephritis: a qualitative analysis.
Cardwell, Francesca S; Elliott, Susan J; Barber, Megan R W; Cheema, Kim; George, Sydney; Boucher, Adrian; Clarke, Ann Elaine.
Afiliación
  • Cardwell FS; Department of Geography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada fcardwel@uwaterloo.ca.
  • Elliott SJ; Department of Geography and Environmental Management, University of Waterloo, Waterloo, Ontario, Canada.
  • Barber MRW; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Cheema K; Division of Nephrology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • George S; Health Outcomes and Economics, GSK, Mississauga, Ontario, Canada.
  • Boucher A; Health Outcomes and Economics, GSK, Mississauga, Ontario, Canada.
  • Clarke AE; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lupus Sci Med ; 10(2)2023 12 09.
Article en En | MEDLINE | ID: mdl-38087643
ABSTRACT

OBJECTIVE:

Lupus nephritis (LN) is one of the most severe manifestations of SLE; however, we know little about the lived experience of LN. This research investigates patient experiences and perspectives of (1) LN diagnosis; (2) living with LN; and (3) LN healthcare and treatment.

METHODS:

Patients aged ≥18 years with biopsy-proven pure or mixed International Society of Nephrology/Renal Pathology Society class III, IV or V LN were purposefully recruited from a Canadian lupus cohort to participate in semistructured in-depth interviews.

RESULTS:

Thirty patients with LN completed the interviews. The mean (SD) age was 42.1 (16.4) years, and 86.7% were female. Participants described challenges seeking, receiving and adjusting to a LN diagnosis, and some reported that their diagnosis process took weeks to years. While 16 participants were provided resources by healthcare providers to help them through the process of diagnosis, the need for accessible LN-specific information at diagnosis was highlighted (n=18). Participants also described the unpredictability of living with LN, particularly related to impacts on physical and mental health, relationships, leisure activities, employment and education, and family planning. While most (n=26) participants reported a positive impression of their care, the side effects of LN medications and the need to increase patient and societal awareness/understanding of LN were highlighted in the context of healthcare and treatment.

CONCLUSIONS:

The unpredictability of living with LN, the heavy treatment burden and a lack of patient/societal awareness substantially affect the lived experience of LN. These findings will inform the development of LN-specific patient resources to increase understanding of LN and improve well-being for patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Lupus Eritematoso Sistémico Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Lupus Sci Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Lupus Eritematoso Sistémico Límite: Adolescent / Adult / Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Lupus Sci Med Año: 2023 Tipo del documento: Article País de afiliación: Canadá